Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

Pain

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Alemtuzumab for B-cell chronic lymphocytic leukemia.

Issues in emerging health technologies·2005

Same author

Effect of amantadine on motor memory consolidation in humans.

Behavioural pharmacology·2005

Same author

Bevacizumab for advanced colorectal cancer.

Issues in emerging health technologies·2004

Same author

Omalizumab as add-on therapy to inhaled steroids for asthma.

Issues in emerging health technologies·2004

Same author

[Pathophysiology and therapy of L-Dopa-induced dyskinesia].

Revue neurologique·2004

Same author

New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.

Advances in neurology·2002

Search research articles

Related Experiment Video

Updated: Jan 14, 2026

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

Pregabalin for peripheral neuropathic pain.

Issues in Emerging Health Technologies

|April 6, 2005

Summary

Pregabalin effectively reduces neuropathic pain (NeP) in adults, showing significant pain score decreases in clinical trials. However, common side effects like dizziness and sleepiness, and higher withdrawal rates, warrant consideration.

Area of Science:

Pharmacology and Therapeutics
Neurology
Pain Management

Background:

Pregabalin, an anticonvulsant, is under review for Canadian use.
Recently approved in the US and Europe for adult peripheral neuropathic pain (NeP).
NeP encompasses conditions like diabetic peripheral neuropathy (DPN) and post-herpetic neuralgia (PHN).

Purpose of the Study:

To evaluate the efficacy and safety of pregabalin for NeP treatment.
To assess pregabalin's effectiveness in reducing pain scores and improving patient outcomes.
To compare pregabalin's benefits against placebo in randomized controlled trials (RCTs).

Main Methods:

Analysis of short-term randomized controlled trials (RCTs).
Inclusion of patients with diabetic peripheral neuropathy (DPN) and post-herpetic neuralgia (PHN).

More Related Videos

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

Related Experiment Videos

Last Updated: Jan 14, 2026

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

Assessment of pain score reduction and adverse events.

Main Results:

Significant and early decreases in mean pain scores observed in pregabalin groups.
Increased proportion of subjects achieving >50% pain reduction compared to placebo.
Common adverse effects included dizziness and somnolence; higher withdrawal rates due to adverse events were noted.

Conclusions:

Pregabalin demonstrates efficacy in treating peripheral neuropathic pain (NeP).
The drug's effectiveness is supported by significant pain reduction in RCTs.
Current evidence does not indicate advantages over existing Canadian treatments, considering side effect profile.